Trial Profile
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 Sep 2018
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Triamcinolone
- Indications Retinal oedema
- Focus Adverse reactions
- 08 Sep 2018 Status changed from recruiting to completed.
- 24 Apr 2017 Planned End Date changed from 1 Nov 2017 to 1 Nov 2020.
- 24 Apr 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2019.